These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 10492516)
1. Striatum adenosine A2 receptors are modified during seizure: effect of cyclopentyladenosine administration. Giraldez L; Zanetti F; Girardi E Neurochem Res; 1999 Oct; 24(10):1217-23. PubMed ID: 10492516 [TBL] [Abstract][Full Text] [Related]
2. Modification of [3H]MK801 binding to rat brain NMDA receptors after the administration of a convulsant drug and an adenosine analogue: a quantitative autoradiographic study. Giraldez L; Girardi E Neurochem Res; 1998 Oct; 23(10):1327-36. PubMed ID: 9804290 [TBL] [Abstract][Full Text] [Related]
3. Effects of an adenosine analogue administration on the striatal NMDA receptors in an experimental model of epilepsy. Giraldez L; Girardi E Neurochem Int; 2000 Mar; 36(3):243-7. PubMed ID: 10676859 [TBL] [Abstract][Full Text] [Related]
4. CNS adenosine A1 receptors are altered after the administration of convulsant 3-mercaptopropionic acid and cyclopentyladenosine: an autoradiographic study. Giraldez L; Zanetti F; Antonelli MC; Rodríguez de Lores Arnaiz G; Girardi E Neurochem Res; 1998 Feb; 23(2):175-81. PubMed ID: 9475512 [TBL] [Abstract][Full Text] [Related]
5. Ligand binding to CNS muscarinic receptor is transiently modified by convulsant 3-mercaptopropionic acid administration. Schneider PG; de Lores Arnaiz GR Neurochem Res; 2000 May; 25(5):637-43. PubMed ID: 10905625 [TBL] [Abstract][Full Text] [Related]
7. 3-Mercaptopropionic acid-induced repetitive seizures increase GluN2A expression in rat hippocampus: a potential neuroprotective role of cyclopentyladenosine. Gori MB; Girardi E Cell Mol Neurobiol; 2013 Aug; 33(6):803-13. PubMed ID: 23748434 [TBL] [Abstract][Full Text] [Related]
8. Area-dependent CNS membrane response of muscarinic receptor to convulsant 3-mercaptopropionic acid. Schneider PG; Rodríguez de Lores Arnaiz G Mol Chem Neuropathol; 1997; 32(1-3):213-21. PubMed ID: 9437668 [TBL] [Abstract][Full Text] [Related]
9. Autoradiographic characterization of high-affinity adenosine A2 receptors in the rat brain. Jarvis MF; Jackson RH; Williams M Brain Res; 1989 Apr; 484(1-2):111-8. PubMed ID: 2713675 [TBL] [Abstract][Full Text] [Related]
10. Differential expression of cerebellar metabotropic glutamate receptors mGLUR2/3 and mGLUR4a after the administration of a convulsant drug and the adenosine analogue cyclopentyladenosine. Girardi ES; Canitrot J; Antonelli M; González NN; Coirini H Neurochem Res; 2007 Jul; 32(7):1120-8. PubMed ID: 17401670 [TBL] [Abstract][Full Text] [Related]
11. Evidence for high-affinity binding sites for the adenosine A2A receptor agonist [3H] CGS 21680 in the rat hippocampus and cerebral cortex that are different from striatal A2A receptors. Cunha RA; Johansson B; Constantino MD; Sebastião AM; Fredholm BB Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):261-71. PubMed ID: 8692280 [TBL] [Abstract][Full Text] [Related]
12. Seizure activity produces differential changes in adenosine A1 receptors within rat hippocampus. Vanore G; Giraldez L; Rodríguez de Lores Arnaiz G; Girardi E Neurochem Res; 2001 Mar; 26(3):225-30. PubMed ID: 11495545 [TBL] [Abstract][Full Text] [Related]
13. Further characterization of the binding of the adenosine receptor agonist [3H]CGS 21680 to rat brain using autoradiography. Johansson B; Fredholm BB Neuropharmacology; 1995 Apr; 34(4):393-403. PubMed ID: 7566470 [TBL] [Abstract][Full Text] [Related]
14. Differential development of adenosine A1 and A2b receptors in the rat duodenum. Peachey JA; Hourani SM; Kitchen I Br J Pharmacol; 1996 Nov; 119(5):949-58. PubMed ID: 8922745 [TBL] [Abstract][Full Text] [Related]
15. A study of 5'-nucleotidase activity in subcellular fractions of rat cerebellum after the administration of the convulsant 3-mercaptopropionic acid. Girardi E; Perez Raffo G; Rodriguez de Lores Arnaiz G Mol Chem Neuropathol; 1989 Oct; 11(2):65-75. PubMed ID: 2561415 [TBL] [Abstract][Full Text] [Related]
16. The ontogenetic profiles of the pre- and postjunctional adenosine receptors in the rat vas deferens. Peachey JA; Brownhill VR; Hourani SM; Kitchen I Br J Pharmacol; 1996 Mar; 117(6):1105-10. PubMed ID: 8882603 [TBL] [Abstract][Full Text] [Related]
17. Stimulation of adenosine A1 receptors attenuates dopamine D1 receptor-mediated increase of NGFI-A, c-fos and jun-B mRNA levels in the dopamine-denervated striatum and dopamine D1 receptor-mediated turning behaviour. Ferré S; Rimondini R; Popoli P; Reggio R; Pèzzola A; Hansson AC; Andersson A; Fuxe K Eur J Neurosci; 1999 Nov; 11(11):3884-92. PubMed ID: 10583477 [TBL] [Abstract][Full Text] [Related]
18. Enabling role of adenosine A1 receptors in adenosine A2A receptor-mediated striatal expression of c-fos. Karcz-Kubicha M; Quarta D; Hope BT; Antoniou K; Müller CE; Morales M; Schindler CW; Goldberg SR; Ferré S Eur J Neurosci; 2003 Jul; 18(2):296-302. PubMed ID: 12887411 [TBL] [Abstract][Full Text] [Related]
19. Distribution of D1 and D2 dopamine receptors in the basal ganglia of the cat determined by quantitative autoradiography. Beckstead RM; Wooten GF; Trugman JM J Comp Neurol; 1988 Feb; 268(1):131-45. PubMed ID: 2964456 [TBL] [Abstract][Full Text] [Related]
20. Agonists of A1 and A2A adenosine receptors attenuate methamphetamine-induced overflow of dopamine in rat striatum. Golembiowska K; Zylewska A Brain Res; 1998 Sep; 806(2):202-9. PubMed ID: 9739141 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]